Drug Discovery Company Announces $32 Million Series A
Verge Genomics, a drug discovery company utilizing machine learning to develop new therapeutics, raised $32 million in Series A financing led by DFJ. New biotech investors WuXi AppTec’s Corporate Venture Fund, ALS Investment Fund, Agent Capital, and OS Fund also participated in the round. Founded